Shortened head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope - 09/09/11
Abstract |
Background Head-up tilt testing is extensively used to determine the vasovagal origin of syncope in patients with otherwise unexplained loss of consciousness, although issues remain regarding the method of the test. The diagnostic value of a shortened head-up tilt test potentiated with sublingual nitroglycerin was assessed in patients with unexplained syncope. Methods Two hundred two patients (mean age 49 ± 19 years) with syncope of unknown origin and 34 subjects in a control group (mean age 45 ± 17 years) were studied. The patients and the subjects in the control group were tilted upright to 60 degrees for 20 minutes. If syncope did not occur, sublingual nitroglycerin (400 μg) was administered, and observation was continued for 25 more minutes. Results During the unmedicated phase syncope occurred in 22 (11%) patients and in one member of the control group. After nitroglycerin was administered, syncope occurred in 119 (59%) patients and in 1 (3%) member of the control group. False-positive response (exaggerated response) was observed in eight (4%) patients and in four (12%) subjects in the control group. The total positivity rate of the test was 70% with a specificity rate of 94%. Conclusions Short-duration head-up tilt test potentiated with sublingual nitroglycerin provides an adequate specificity and positivity rate in patients with unexplained syncope. (Am Heart J 1998;135:564-70.)
Le texte complet de cet article est disponible en PDF.Plan
From the aDivision of Cardiology, Ospedale S. Pietro Igneo, Fucecchio, the bDivision of Cardiology, Ospedale G. Giuseppe, Empoli, the cDivision of Internal Medicine, Ospedale S. Verdiana, Castelfiorentino, and the dClinica Medica I, Section of Arrhythmology, University of Florence. |
|
Reprint requests: Attilio Del Rosso, MD, via Francesca 221, 50050 Cerreto Guidi, Florence, Italy. |
|
4/1/88286 |
Vol 135 - N° 4
P. 564-570 - avril 1998 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?